Cuzick, Jack
Sestak, Ivana
Forbes, John F
Dowsett, Mitch
Knox, Jill
Cawthorn, Simon
Saunders, Christobel
Roche, Nicola
Mansel, Robert E
von Minckwitz, Gunter
Bonanni, Bernardo
Palva, Tiina
Howell, Anthony
Clinical trials referenced in this document:
Documents that mention this clinical trial
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
https://doi.org/10.1016/s0140-6736(13)62292-8
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies
https://doi.org/10.1007/s10549-021-06141-7
Funding for this research was provided by:
Cancer Research UK (C569/A5032)
National Health and Medical Research Council Australia (GNT300755, GNT569213)
This article is maintained by: Elsevier
Article Title: Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(13)62292-8
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(13)62555-6
Content Type: article
Copyright: Copyright © 2014 Cuzick et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.